TMBIM4 and hepatocellular carcinoma: Suppression of S1R significantly enhanced cell death of HCC cells induced by both erastin and sorafenib, which could be inhibited by ferroptosis inhibitors (e.g., ferrostatin-1) other than inhibitors of apoptosis or necroptosis.